121 related articles for article (PubMed ID: 8690245)
21. Gastroprotective agents in mucosal defense against Helicobacter pylori.
Slomiany BL; Murty VL; Piotrowski J; Slomiany A
Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
[TBL] [Abstract][Full Text] [Related]
22. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.
Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
Am J Gastroenterol; 1994 Jun; 89(6):894-7. PubMed ID: 8198101
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of gastric mucus phospholipid secretion by an antiulcer agent, ebrotidine.
Slomiany BL; Piotrowski E; Piotrowski J; Zirvi KA; Liau YH; Murty VL; Slomiany A
Gen Pharmacol; 1994 Sep; 25(5):1033-7. PubMed ID: 7835621
[TBL] [Abstract][Full Text] [Related]
24. Effect of ebrotidine on gastric mucosal calcium channel activity.
Slomiany BL; Liu J; Kawai T; Czajkowski A; Slomiany A
Am J Gastroenterol; 1993 Jun; 88(6):881-6. PubMed ID: 8099251
[TBL] [Abstract][Full Text] [Related]
25. Ebrotidine.
Patel SS; Wilde MI
Drugs; 1996 Jun; 51(6):974-80; discussion 981. PubMed ID: 8736619
[TBL] [Abstract][Full Text] [Related]
26. Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine.
Slomiany BL; Piotrowski J; Slomiany A
Scand J Gastroenterol; 1997 Jul; 32(7):638-42. PubMed ID: 9246701
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori lipopolysaccharide inhibition of gastric somatostatin receptor: effect of sucralfate.
Piotrowski J; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1997 Jul; 42(3):545-51. PubMed ID: 9247712
[TBL] [Abstract][Full Text] [Related]
28. Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 2000 Sep; 51(3):421-31. PubMed ID: 11016862
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of EGF-induced gastric mucosal calcium channel phosphorylation by ebrotidine.
Slomiany BL; Liu J; Piotrowski J; Slomiany A
Biochem Int; 1992 Dec; 28(4):751-60. PubMed ID: 1282815
[TBL] [Abstract][Full Text] [Related]
30. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of sucralfate.
Piotrowski J; Yamaki K; Slomiany A; Slomiany BL
Am J Gastroenterol; 1991 Dec; 86(12):1756-60. PubMed ID: 1835819
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of growth factors to degradation by Helicobacter pylori protease: effect of ebrotidine and sucralfate.
Slomiany BL; Piotrowski J; Slomiany A
Biochem Mol Biol Int; 1996 Sep; 40(1):209-15. PubMed ID: 8886287
[TBL] [Abstract][Full Text] [Related]
35. Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide.
Slomiany BL; Piotrowski J; Slomiany A
Scand J Gastroenterol; 1998 Sep; 33(9):916-22. PubMed ID: 9759945
[TBL] [Abstract][Full Text] [Related]
36. Ebrotidine--a nostrum for ulcer.
Grover JK; Rathi SS; Vats V
Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
[No Abstract] [Full Text] [Related]
37. Gastric mucosal laminin receptor expression with ulcer healing by ebrotidine.
Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Majka J; Slomiany A
Gen Pharmacol; 1994 May; 25(3):451-5. PubMed ID: 7926589
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
Slomiany BL; Slomiany A
J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol.
Slomiany BL; Piotrowski J; Murty VL; Slomiany A
Gen Pharmacol; 1992 Jul; 23(4):719-27. PubMed ID: 1356875
[TBL] [Abstract][Full Text] [Related]
40. [Ebrotidine].
Elizalde JI
Gastroenterol Hepatol; 1997 Feb; 20(2):65-7. PubMed ID: 9072206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
